PLURIHORMONAL CELLS OF ANTERIOR PITUITARY. NEW FEATURES TO OPTIMIZE MOLECULAR DIAGNOSIS OF NEUROENDOCRINE TUMORS

DOI: https://doi.org/None

Mitrofanova L.B., Konovalov P.V., Krylova Yu. S., Polyakova V.O., Kvetnoy I.M.

Introduction. Multihormonality is an ability of pituitary cells to produce more than one hormone. A great number of adenomas are multihormonal in the actual practice. We hypothesize cells of a normal pituitary gland to secret several hormones simultaneously. Objective. To investigate the co-expression of hormones by cells of the normal anterior pituitary of adult humans in autopsy material Materials and methods. We studied 10 normal pituitary glands from 4 females and 6 males. Double staining immunohistochemistry using 11 hormone combinations was performed in all the cases. Laser Confocal Scanning Microscopy with a mixture of primary antibodies was performed in 2 cases. Results. We found out same cells of the normal adult human anterior pituitary to be able to co-express PRL with ACTH, TSH, FSH, LH; GH with ACTH, TSH, FSH, LH, and TSH with ACTH, FSH, LH. The comparison of average coefficients of the co-expression of PRL, GH and TSH with other hormones showed the TSH co-expression coefficient to be significantly lower (9,5±6,9%; 9,6±7,8% and 1,0±1,3% correspondingly). Conclusion. Multihormonality of normal anterior pituitary is an actually existing phenomenon. Identification of different hormones in tissue samplesenables to optimize diagnosis and treatment of neuroendocrine tumours.
Keywords: 
multihormonal pituitary cells, confocal microscopy and immunohistochemistry
Список литературы: 
  1. Pawlikowski M., Kunert-Radek J., Radek M. Plurihormonality of pituitary adenomas in light of immunohistochemical studies. Polish Journal of Endocrinology. 2010; 61 (1): 63–6.
  2. DeLellis R.A., Lloyd R.V., Heitz P.U., Eng C. (Eds): World Health Organization Classification of Tumors Pathology and genetics of tumors of endocrine organs. IARC Press: Lyon, 2004; 320.
  3. Kovacs K., Horvath E., Stefaneanu L., Bilbao J., Singer W., Muller PJ., Thapar K, Stone E. Pituitary adenoma producing growth hormone and adrenocorticotropin: a histological, immunocytochemical, electron microscopic, and in situ hybridization study. Case report. J. Neurosurg. 1998; 88 (6): 1111–5.
  4. Matsuno A., Sasaki T., Kirino T. Plurihormonal pituitary tumor. J. Neurosurg. 1999; 90 (3): 608–9.
  5. Scheithauer B.W., Horvath E., Kovacs K., Laws E.R. Jr., Randall R.V., Ryan N. Plurihormonal pituitary adenomas. Semin. Diagn. Pathol. 1986; 3 (1): 69–82.
  6. Budan R.M., Georgescu C.U. Multiple pituitary adenomas: a systematic review. Front Endocrinol. (Lausanne). 2016; 7: 1. doi: 10.3389/fendo.2016.00001.
  7. Zhu X., Gleibeman A.S., Rosenfeld M.G. Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol. Rev. 2007; 87 (3): 933–63.
  8. Asa S.L., Ezzat S. Molecular basis of pituitary development and cytogenesis. Front. Horm. Res. 2004; 32: 1–19.
  9. Vidal S., Syro L., Horvath E., Uribe H., Kovacs K. Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas. Ultrastruct. Pathol. 1999; 23 (3): 141–8.
  10. Vidal S., Horvath E., Kovacs K., Cohen SM., Lloyd RV., Scheithauer BW. Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism. Virchows Arch. 2000; 436 (1): 43–51.
  11. Felix I., Asa SL., Kovacs K., Horvath E., Smyth HS. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Arch. Pathol. Lab. Med. 1994; 118 (1): 66–70.
  12. Sanno N., Tahara S., Kurotani R., Matsuno A., Teramoto A., Osamura RY. Cytochemical and molecular biological aspects of the pituitary and pituitary adenomas-cell differentiation and transcription factors. Proq. Histochem. Cytochem. 2001; 36 (4): 263–99.
  13. Magri F., Villa C., Locatelli D., Scagnelli P., Lagonigro MS, Morbini P., Castellano M., Gabellieri E., Rotondi M., Solcia E., Daly AF., Chiovato L. Prevalence of double pituitary adenomas in a surgical series: clinical, histological and genetic features. J. Endocrinol. Invest. 2010; 33 (5): 325–31.
  14. Jastania R.A., Alsaad K.O., Al-Shraim M., Kovacs K., Asa S.L. Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation. Endorc. Pathol. 2005; 16 (3): 187–94.
  15. Melmed S. Pathogenesis of pituitary tumors. Nat. Rev. Endocrinol. 2011; 7 (5): 257–66.
  16. Kontogeorgos G., Scheithauer B.W., Horvath E., Kovacs K., Lloyd R.V., Smyth H.S., Rologis D. Double adenomas of the pituitary: a clinicopathological study of 11 tumors. Neurosurgery. 1992; 31 (5): 840–9.
  17. Lyons J., Landis C.A., Harsh G., Vallar L., Grünewald K., Feichtinger H., Duh Q.Y., Clark O.H., Kawasaki E., Bourne H.R. Two G protein oncogenes in human endocrine tumors. Science. 1990; 249 (4969): 655–9.
  18. Chesnokova V., Melmed S. Pituitary tumour-transforming gene (PTTG) and pituitary senescence. Horm. Res. 2009; 71 (2): 82–7.